NASDAQ: BSLKBolt Projects Holdings Inc Stock
$1.47-0.09 (-5.77%)
Updated Nov 20, 2025
BSLK Price
$1.47
Fair Value Price
N/A
Market Cap
$6.42M
52 Week Low
$1.47
52 Week High
$25.00
P/E
0.05x
P/B
-0.5x
P/S
3.33x
PEG
0x
Dividend Yield
N/A
Revenue
$3.14M
Earnings
-$24.28M
Gross Margin
3.2%
Operating Margin
-725.45%
Profit Margin
-774.2%
Debt to Equity
-1.87
Operating Cash Flow
-$5M
Beta
0.68
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BSLK Overview
Golden Arrow Merger Corp. is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. It targets businesses in the healthcare and healthcare-related infrastructure sectors. Golden Arrow Merger was incorporated in 2020 and is based in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine BSLK's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More
Zen Rating Component Grades
F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Specialty Chemical
Industry Rating
C
BSLK
Ranked#51 of 53
Ranked#51 of 53
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $47.48 | A | |
| $11.62 | A | |
| $53.96 | A |
Be the first to know about important BSLK news, forecast changes, insider trades & much more!
BSLK News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BSLK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BSLK ($1.47) is trading below its intrinsic value of $486.57, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BSLK is good value based on its earnings relative to its share price (0.05x), compared to the US market average (42.99x)
P/E vs Market Valuation
BSLK is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more BSLK due diligence checks available for Premium users.
Valuation
BSLK price to earnings (PE)
For valuing profitable companies with steady earnings
Company
0.05x
Industry
-1.37x
Market
42.99x
BSLK is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BSLK is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
BSLK price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.5x
Industry
2.99x
BSLK price to earnings growth (PEG)
For valuing profitable companies with growth potential
BSLK is good value based... subscribe to Premium to read more.
PEG Value Valuation
BSLK's financial health
Profit margin
Revenue
$370.0k
Net Income
-$7.5M
Profit Margin
-2,021.1%
BSLK's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
BSLK's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$11.1M
Liabilities
$23.9M
Debt to equity
-1.87
BSLK's short-term liabilities ($10.59M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BSLK's long-term liabilities ($13.29M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BSLK's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BSLK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$301.0k
Investing
-$1.0k
Financing
$3.5M
BSLK's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
BSLK vs Specialty Chemical Stocks
Bolt Projects Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.